Healthcare & life sciences
Building pricing infrastructure for life science companies
Pricing pressure across healthcare and life sciences is intensifying. Tariffs are reshaping cost structures, customers are demanding more value, and competition for service contracts is compressing margins year over year.


Our Sub-Industries for Healthcare & life sciences
- CROs/CDMOs
- Pharmaceuticals & BioTech
- Medical Devices & MedTech
- Diagnostics & Laboratory Services
- Healthcare Software & Digital Health
- Process Industries
- Technical Support & Field Services
In health and life sciences, the problem is rarely strategy, it’s infrastructure.
Discount authority is unclear, annual increases get deferred, and pricing decisions live in spreadsheets. We help life sciences companies build the pricing discipline that holds, from diagnostics to governance to execution.
The Key Problems
We solve the biggest pricing challenges for healthcare & life sciences.
Life Sciences companies operate in a market defined by rising input costs, tightening customer expectations, and shrinking service margins. Price pressure is constant, but cutting price is not the answer and rarely solves the underlying commercial challenge. Sustainable advantage comes from pricing infrastructure, commercial discipline, and execution consistency across every customer segment and channel. Too many firms react to pressure with discounts that compound over time, quietly eroding the margin base and weakening long-term positioning.
We help Life Sciences firms build pricing that holds under pressure, protects value, and improves margin year over year.
Our team
Subject matter experts
Our team brings experience in regulated pricing environments, helping organizations balance access, compliance, and profitability through structured pricing approaches.
Michael Stanisz
Partner
Joel Dienye
Director